会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Stable salt of 3′-phosphoadenosine 5′-phosphosulfate
    • 3'-磷酸腺苷5'-磷酸硫酸盐的稳定盐
    • US07863438B2
    • 2011-01-04
    • US12093743
    • 2006-11-16
    • Kazuya IshigeTakashi KawakamiToshitada Noguchi
    • Kazuya IshigeTakashi KawakamiToshitada Noguchi
    • C07H19/22
    • C07H19/20
    • The present invention provides a stable salt of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) and a production method therefor.The present invention is directed to a stable salt of PAPS (amine salt), which is formed between PAPS and an amine compound, and to a method for producing a stable salt of PAPS, which includes adding an amine compound to an aqueous PAPS solution in an amount by mole equal to or greater than that of PAPS, and lyophilizing the resultant solution.The present invention has first realized production of a solid-form PAPS salt having considerably improved stability through a very simple technique. Since the thus-produced amine salt of PAPS is very stable, the salt can be stored or employed without taking much care about decomposition thereof at ambient temperature.
    • 本发明提供稳定的3'-磷酸腺苷5'-磷酸硫酸盐(PAPS)及其制备方法。 本发明涉及在PAPS和胺化合物之间形成的PAPS(胺盐)的稳定盐,以及PAPS稳定盐的制备方法,其包括向PAPS水溶液中加入胺化合物 摩尔量等于或大于PAPS的量,并冻干所得溶液。 本发明首先通过非常简单的技术实现了具有显着提高的稳定性的固体PAPS盐的生产。 由于如此制得的PAPS胺盐非常稳定,所以可以在不在室温下分解的情况下储存或使用该盐。
    • 2. 发明申请
    • STABLE SALT OF 3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE
    • 稳定的3'-磷酸腺苷5'-磷酸肌酸盐
    • US20090118491A1
    • 2009-05-07
    • US12093743
    • 2006-11-16
    • Kazuya IshigeTakashi KawakamiToshitada Noguchi
    • Kazuya IshigeTakashi KawakamiToshitada Noguchi
    • C07H19/20
    • C07H19/20
    • The present invention provides a stable salt of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) and a production method therefor.The present invention is directed to a stable salt of PAPS (amine salt), which is formed between PAPS and an amine compound, and to a method for producing a stable salt of PAPS, which includes adding an amine compound to an aqueous PAPS solution in an amount by mole equal to or greater than that of PAPS, and lyophilizing the resultant solution.The present invention has first realized production of a solid-form PAPS salt having considerably improved stability through a very simple technique. Since the thus-produced amine salt of PAPS is very stable, the salt can be stored or employed without taking much care about decomposition thereof at ambient temperature.
    • 本发明提供稳定的3'-磷酸腺苷5'-磷酸硫酸盐(PAPS)及其制备方法。 本发明涉及在PAPS和胺化合物之间形成的PAPS(胺盐)的稳定盐,以及PAPS稳定盐的制备方法,其包括向PAPS水溶液中加入胺化合物 摩尔量等于或大于PAPS的量,并冻干所得溶液。 本发明首先通过非常简单的技术实现了具有显着提高的稳定性的固体PAPS盐的生产。 由于如此制得的PAPS胺盐非常稳定,所以盐可以在环境温度下储存或使用而不用担心其分解。
    • 4. 发明申请
    • METHOD OF ENZYMATICALLY SYNTHESIZING 3' -PHOSPHOADENOSINE-5' -PHOSPHOSULFATE
    • 精氨酸合成3'-磷酰基-5'-磷酸脂肪酸酯的方法
    • US20090215114A1
    • 2009-08-27
    • US11814700
    • 2006-01-24
    • Kazuya IshigeToshitada Noguchi
    • Kazuya IshigeToshitada Noguchi
    • C12P21/02C07H21/04C12P19/32C12N9/12
    • C12N9/1229C12N9/1205C12N9/1241C12P19/32
    • The invention provides a method for producing 3′-phosphoadenosine 5′-phosphosulfate (PAPS), the method including subjecting ATP to sulfation and phosphorylation by use of adenosine 5′-triphosphate sulfurylase (ATPS) and adenosine 5′-phosphosulfate kinase (APSK), wherein an adenosine 5′-triphosphate (ATP) supply/regeneration system including adenosine 5′-monophosphate (AMP), polyphosphate, polyphosphate-driven nucleoside 5′-diphosphate kinase (PNDK), and polyphosphate:AMP phosphotransferase (PAP), or an adenosine 5′-triphosphate (ATP) supply/regeneration system including adenosine 5′-monophosphate (AMP), polyphosphate, polyphosphate-driven nucleoside 5′-diphosphate kinase (PNDK), and adenylate kinase (ADK) is employed instead of ATP.
    • 本发明提供了一种制备3'-磷酸腺苷5'-磷酸硫酸(PAPS)的方法,该方法包括使用腺苷5'-三磷酸硫酸化酶(ATPS)和腺苷5'-磷酸硫酸激酶(APSK)对ATP进行硫酸化和磷酸化, ,其中包括腺苷5'-单磷酸(AMP),多磷酸盐,多磷酸盐驱动的核苷5'-二磷酸激酶(PNDK)和多磷酸盐:AMP磷酸转移酶(PAP)的腺苷5'-三磷酸(ATP)供应/再生系统,或 使用包括腺苷5'-单磷酸(AMP),多磷酸盐,多磷酸盐驱动的核苷5'-二磷酸激酶(PNDK)和腺苷酸激酶(ADK)的腺苷5'-三磷酸(ATP)供应/再生系统代替ATP。
    • 7. 发明申请
    • SUGAR CHAIN CONTAINING 4-POSITION HALOGENATED GALACTOSE AND APPLICATION THEREOF
    • 含有4-位羟基糖的糖链及其应用
    • US20090018327A1
    • 2009-01-15
    • US11815329
    • 2006-02-14
    • Shin-Ichiro NishimuraNoriko NagahoriTomoki HamamotoKiyoshi OkuyamaToshitada Noguchi
    • Shin-Ichiro NishimuraNoriko NagahoriTomoki HamamotoKiyoshi OkuyamaToshitada Noguchi
    • C07H5/02C12P19/30
    • C12P19/32C07H15/08
    • The present invention is directed to, for example, an oligosaccharide having at an end thereof a 4-position halogenated galactose residue represented by formula (I): (wherein X represents a halogen atom, and R represents a monosaccharide, an oligosaccharide, or a carrier), a transferase inhibitor containing the oligosaccharide, and a method for inhibiting sugar chain elongation reaction in the presence of glycosyltransferase, the method including employing the inhibitor.The invention also provides a method for producing a 4-position halogenated galactose sugar nucleotide represented by formula (II): (wherein each of R1 to R3 represents a hydroxyl group, an acetyl group, a halogen atom, or a hydrogen atom; X represents a halogen atom; and M represents a hydrogen ion or a metal ion), wherein the method employs bacterium-derived galactokinase and bacterium-derived hexose-1-phosphate uridylyltransferase.The invention is also directed to a sugar chain containing 4-position halogenated galactose envisaged to be employed as drugs and other materials, and to applications of the compound.
    • 本发明涉及例如末端具有由式(I)表示的4-位卤代半乳糖残基的寡糖:(其中,X表示卤素原子,R表示单糖,寡糖,或 载体),含有寡糖的转移酶抑制剂,以及在糖基转移酶存在下抑制糖链延长反应的方法,该方法包括使用该抑制剂。 本发明还提供了由式(II)表示的4-位卤代半乳糖糖核苷酸的制备方法:(式中,R 1〜R 3各自表示羟基,乙酰基,卤素原子或氢原子; X表示 卤素原子; M表示氢离子或金属离子),其中该方法采用细菌来源的半乳糖激酶和细菌来源的己糖-1-磷酸尿苷酰转移酶。 本发明还涉及设想用作药物和其它材料的4-位卤代半乳糖的糖链以及该化合物的应用。
    • 10. 发明授权
    • Sugar chain containing 4-position halogenated galactose and application thereof
    • 含有4-位卤代半乳糖的糖链及其应用
    • US08148112B2
    • 2012-04-03
    • US11815329
    • 2006-02-14
    • Shin-Ichiro NishimuraNoriko NagahoriTomoki HamamotoKiyoshi OkuyamaToshitada Noguchi
    • Shin-Ichiro NishimuraNoriko NagahoriTomoki HamamotoKiyoshi OkuyamaToshitada Noguchi
    • C12P19/50C12P19/52C12P19/26C07H15/00C07H5/04C07H5/06C08B37/00
    • C12P19/32C07H15/08
    • The present invention is directed to, for example, an oligosaccharide having at an end thereof a 4-position halogenated galactose residue represented by formula (I): (wherein X represents a halogen atom, and R represents a monosaccharide, an oligosaccharide, or a carrier), a transferase inhibitor containing the oligosaccharide, and a method for inhibiting sugar chain elongation reaction in the presence of glycosyltransferase, the method including employing the inhibitor. The invention also provides a method for producing a 4-position halogenated galactose sugar nucleotide represented by formula (II): (wherein each of R1 to R3 represents a hydroxyl group, an acetyl group, a halogen atom, or a hydrogen atom; X represents a halogen atom; and M represents a hydrogen ion or a metal ion), wherein the method employs bacterium-derived galactokinase and bacterium-derived hexose-1-phosphate uridylyltransferase. The invention is also directed to a sugar chain containing 4-position halogenated galactose envisaged to be employed as drugs and other materials, and to applications of the compound.
    • 本发明涉及例如末端具有由式(I)表示的4位卤代半乳糖残基的寡糖:(其中X表示卤素原子,R表示单糖,寡糖或 载体),含有寡糖的转移酶抑制剂,以及在糖基转移酶存在下抑制糖链延长反应的方法,该方法包括使用该抑制剂。 本发明还提供了由式(II)表示的4-位卤代半乳糖糖核苷酸的制备方法:(式中,R 1〜R 3各自表示羟基,乙酰基,卤素原子或氢原子; X表示 卤素原子; M表示氢离子或金属离子),其中该方法采用细菌来源的半乳糖激酶和细菌来源的己糖-1-磷酸尿苷酰转移酶。 本发明还涉及设想用作药物和其它材料的4-位卤代半乳糖的糖链以及该化合物的应用。